FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
Bernstein raised its price target on UnitedHealth Group (NYSE: UNH) to $275.00 (from $259.00) while maintaining a Outperform rating.
Analyst Lance Wilkes listed the following key observations:
Balanced, diversified growthOptum 29% earnings growthOptumCare is top opportunity for UNH -Long term government MCO growthWe think Global will become next LT growth engine... More
Oppenheimer raised its price target on UnitedHealth Group (NYSE: UNH) to $276.00 (from $260.00) while maintaining a Outperform rating.
Analyst Michael Wiederhorn commented, "UNH reported 1Q:18 adj. EPS of $3.04 (GAAP: $2.87, incl. amortization) vs. OPCO/Street estimates of $2.92/$2.90. Underlying results were solid across both businesses, with Optum generating 29%... More
Credit Suisse raised its price target on UnitedHealth Group (NYSE: UNh) to $270.00 (from $260.00) while maintaining a Outperform rating.
... MoreRBC Capital raised its price target on UnitedHealth Group (NYSE: UNH) to $282.00 (from $280.00) while maintaining an Outperform rating.
Analyst Frank Morgan called it another impressive performance quarterly performance from UNH with each of its business lines posting double-digit earnings growth.
In addition, underlying business trends remain strong.
... MoreEvercore ISI raised its price target on UnitedHealth Group (NYSE: UNH) to $275.00 (from $255.00) while maintaining an Outperform rating.
Analyst Michael Newshel commented, "UNH didnt even catch a sniffle in Q1 and put up an even stronger beat than recent quarters despite the... More
Cantor Fitzgerald raised its price target on UnitedHealth Group (NYSE: UNH) to $300.00 (from $280.00) while maintaining a Overweight rating, following the company's first quarter earnings report.
Analyst Steven Halper notes an upbeat outlook on the shares, as UNH reported 2018 first quarter earning per share and... More
By Caroline Humer and Tamara Mathias
(Reuters) - UnitedHealth Group Inc (NYSE: UNH), the largest U.S. health insurer, on Tuesday reassured investors that the pervasive flu season did not crimp first-quarter earnings as had been feared, boosting its shares as well as those of rivals.
The insurer's quarterly profit beat estimates as it kept medical costs within estimates and it raised its 2018 outlook.
Shares of UnitedHealth rose 3.1 percent to $237.46 and boosted other stocks in the sector on hopes that rivals would also release robust results over the next few weeks.
... More
